Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
Journal article
Howell I. et al, (2023), JMIR Research Protocols, 12, e46741 - e46741
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.
Journal article
Wing PAC. et al, (2023), PLoS pathogens, 19
Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae
Journal article
Brown MA. et al, (2023), Frontiers in Cellular and Infection Microbiology, 13
Editorial: MAIT cells come of age
Journal article
Corbett AJ. et al, (2023), Frontiers in Immunology, 14
Healthy volunteer symptom profile following research bronchoscopy
Conference paper
Morrison H. et al, (2023), EUROPEAN RESPIRATORY JOURNAL, 62
MAIT cells and the microbiome.
Journal article
Jabeen MF. and Hinks TSC., (2023), Frontiers in immunology, 14
BIO-AST Biologics for chronic severe asthma: a network meta-analysis
Journal article
Crossingham I. et al, (2022), Cochrane Database of Systematic Reviews, 2022
Method development for flow-cytometric analysis of primary human airway epithelia infected with non-typeable Haemophilus influenzae
Conference paper
Horton KL. et al, (2022), 03.02 - Airway cell biology and immunopathology
Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ ( FeNO ) framework
Journal article
Couillard S. et al, (2022), Respirology, 27, 573 - 577
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing.
Journal article
Couillard S. et al, (2022), Thorax
Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies
Journal article
Jabeen MF. et al, (2022), Microbiology Spectrum, 10
An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity
Preprint
Schmidt NM. et al, (2022)
The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing
Journal article
Kanellakis NI. et al, (2022), The Lancet Microbe, 3, e294 - e302
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
Journal article
Couillard S. et al, (2022), ERJ Open Research, 00570 - 2021
Development of a Prototype ORACLE Web-app to Predict Treatment Benefits of Type-2 Targeted Anti-Inflammatory Treatment in Asthma
Conference paper
Do W. et al, (2022), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 205
EPITHELIAL IMMUNE ACTIVATION AND INTRACELLULAR INVASION BY NON-TYPEABLE HAEMOPHILUS INFLUENZAE
Conference paper
Brown MA. et al, (2022), THORAX, 77, A38 - A38